Western blot results showed that knockdown of BCL2 remedied F. nucleatum-reduced Caspase-3 and GSDME activation in chemotherapy-treated CRC cells (Figures 3a & 3b, Figure S2C). Here, GSDME is linked to colorectal carcinoma.